Archived articles

Covid-19 vaccine

COVID-19
Study: Children's antibody responses to COVID-19 are stronger than adults'
Published March 22, 2022
Findings differ from earlier reports of low antibody responses in children exposed to COVID-19 virus and suggest that even the youngest children may respond to vaccines if correct dose is determined
Coronavirus
Key COVID-19 metrics decline, but experts say it's far from over
Published Feb 28, 2022
COVID-19 is inching toward endemic status in the U.S., but a clear seasonal pattern has yet to emerge. Meanwhile less than 66% of the total population has been vaccinated.
COVID-19
COVID-19 vaccine maintains strong protection against severe disease at six months
Published Feb 22, 2022
A pre-omicron study reviewed four vaccines, finding that they retain nearly all of their ability to prevent severe disease up to six months after full vaccination
Q+A
Training ambassadors to talk to vaccine-hesitant parents
Published Feb 17, 2022
Rupali Limaye of the Bloomberg School of Public Health discusses the creation of a free virtual course for parents, teachers, and school staff to help them encourage other caregivers to make evidence-based decisions about vaccinating their children
Q+A
Yes, you should get a booster
Published Jan 11, 2022
From preventing COVID-19 altogether to lessening symptoms and transmission with breakthrough infections, there are several good reasons to get an mRNA booster ASAP
Q+A
Making sense of the messiness of omicron
Published Jan 10, 2022
In this Q+A, experts from the Johns Hopkins Bloomberg School of Public Health address some common questions and scenarios with what is known right now
Q+A
Without global vaccinations, further variants ahead
Published Dec 21, 2021
Vaccine experts Anna Durbin and William Moss explain how vaccination prevents viral mutation, discuss remaining barriers to global vaccine access
Coronavirus
COVID-19 continues to hound U.S. with new surge, new variant
Published Dec 21, 2021
As the pandemic's second year ends, the nation struggles to avoid a repeat of widespread lockdowns. But vaccinations continue to tame the impact—for now.
COVID-19 briefing
Omicron variant is likely everywhere, delta cases increasing
Published Dec 6, 2021
Delta remains dominant around the world while omicron emerges, though time will tell whether the new variant will challenge vaccine effectiveness
Data tracking
Tracker finds widespread discrepancies in school COVID-19 policies
Published Nov 22, 2021
Variation occurs not only between states but also within states as individual districts adopt policies at odds with state guidelines